Campillo, Ana <br/><br/>
[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection].  [electronic resource] 

 -  Medicina clinica  Sep 2016 
 - 199-201 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1578-8989 
<br/><br/><label>Standard No.: </label>10.1016/j.medcli.2016.05.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amoxicillin--therapeutic use<br/>Antacids--therapeutic use<br/>Anti-Bacterial Agents--therapeutic use<br/>Bismuth--therapeutic use<br/>Clarithromycin--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori<br/>Humans<br/>Male<br/>Metronidazole--therapeutic use<br/>Middle Aged<br/>Proton Pump Inhibitors--therapeutic use<br/>Retrospective Studies<br/>Treatment Outcome